Results 131 to 140 of about 6,454 (219)

Metabolic Outcomes in Patients With Type 2 Diabetes Prescribed Incretin‐Based Therapy and Referred or Not to a Weight Management Clinic: A Single‐Center Retrospective Analyses

open access: yesObesity Science &Practice, Volume 12, Issue 1, February 2026.
ABSTRACT Background Incretin therapies yield strong metabolic improvements, but whether adding a weight‐management (WM) clinic confers additional benefit beyond pharmacotherapy alone in routine care is unclear. Objective Evaluate whether referral to WM clinic, alongside standard diabetes care, provides additional benefit for adults with type 2 diabetes
Kathleen M. Robinson   +5 more
wiley   +1 more source

If treating obesity with GLP‐1‐based therapies protects the heart, could it also prevent cancer or improve cancer outcomes? The case for randomized trials

open access: yes
Diabetes, Obesity and Metabolism, Volume 28, Issue 3, Page 1599-1602, March 2026.
Anastasios Tentolouris   +1 more
wiley   +1 more source

Development of the Weight and Emotions Scale (WES)

open access: yesObesity Science &Practice, Volume 12, Issue 1, February 2026.
ABSTRACT Objective Obesity and overweight are associated with significant psychosocial burden. Existing patient‐reported outcome (PRO) measures only assess a subset of emotion‐related concepts that are relevant to individuals living with these conditions.
Chisom Kanu   +6 more
wiley   +1 more source

The Worldwide Problem of Obesity - Comparison of the Effectiveness of Pharmacological Treatment with Semaglutide and Tirzepatide in Reducing Body Weight [PDF]

open access: yes
Introduction Obesity is a disease that has been affecting an increasing number of people in the last decade. In addition to surgical and dietary treatment, pharmacological treatment plays an important role in its treatment.
Brudniak, Katarzyna   +7 more
core   +1 more source

Advances in Therapeutic Antibody Discovery and Development Targeting G Protein‐Coupled Receptors

open access: yesPharmacology Research &Perspectives, Volume 14, Issue 1, February 2026.
ABSTRACT G protein‐coupled receptors (GPCRs) are integral to numerous biological processes and are associated with various diseases across all therapeutic areas. Consequently, GPCRs present substantial potential for antibody‐based therapies. This review offers an overview of the therapeutic GPCR‐antibody target landscape and examines the diversity ...
Catherine J. Hutchings   +6 more
wiley   +1 more source

The Tirzepatide Drop: Beware of Slimmer’s Paralysis

open access: yesJournal of Investigative Medicine High Impact Case Reports
This case series explores the association between tirzepatide-assisted weight loss and the development of foot drop due to peroneal nerve neuropathy, a phenomenon known as slimmer’s paralysis.
John M. Tucker MD, Jordan Ritchie MD
doaj   +1 more source

An Original PEG‐Functionalized PS Resin Enables Synthesis of Difficult Peptides: Application to Tirzepatide

open access: yesChemistrySelect, Volume 11, Issue 6, 12 February 2026.
The Seplife Fmoc‐RinkAmide‐PS‐PEG resin, a PEG‐grafted PS resin with optimized composition enables improved swelling and higher loading for SPPS. This resin delivers efficient couplings and high crude purities, supporting reliable synthesis of long and complex peptides.
Ashish Kumar   +12 more
wiley   +1 more source

Tirzepatide - role in obesity, health and physical wellness. Information overview [PDF]

open access: yes
Nowadays there is an increasing number of people with overweight and obesity all around the world. Unhealthy food, sweets and fast foods are available everywhere, that causes self-perpetuating problem.
Białek, Agata   +6 more
core   +1 more source

A New Framework for Understanding Hair‐Driven Medical Decisions

open access: yes
International Journal of Dermatology, Volume 65, Issue 3, Page 429-432, March 2026.
Jeffrey Donovan
wiley   +1 more source

Home - About - Disclaimer - Privacy